http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11189540-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_137d7a341b2b3ca1874b7633d023e6b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1317f9d9fa7762db4252973d1dd2b8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fef3d384472c3e13f43e293663fe1c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37be5bb377a508698866163055270df4
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
filingDate 1997-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d3d4603f000043da90ebf1537d7c6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e29ca7380c7d4c9509ed9b733851ebaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_922259e2a6e57db5484856cecb50f796
publicationDate 1999-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H11189540-A
titleOfInvention Testosterone-5α-reductase inhibitor
abstract (57) [Summary] Piper Metishikum (Piper Met) (Hysticum) or an extract thereof as an active ingredient, and can be used as a skin external preparation or an oral administration preparation. [Effect] It has excellent testosterone-5α-reductase inhibitory activity and can be suitably used as an external preparation for skin, an oral administration agent, etc., alopecia, acne (acne vulgaris), benign prostatic hyperplasia, prostate It is useful for prevention and treatment of cancer and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014234248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19933857-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9144542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0106995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0106996-A1
priorityDate 1997-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID286065
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID130404
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID430084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14127
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414984
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID185670
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID430084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424535195
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID286065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506651
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9833
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID130404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59327
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID191550
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID184699

Total number of triples: 51.